Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $423,864 - $597,960
-7,200 Reduced 22.43%
24,900 $2 Million
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $3.83 Million - $5.11 Million
-74,900 Reduced 70.0%
32,100 $2 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $5.58 Million - $7.81 Million
100,300 Added 1497.01%
107,000 $6.63 Million
Q3 2023

Nov 15, 2023

BUY
$60.27 - $90.75 $403,809 - $608,025
6,700 New
6,700 $465,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.38B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.